Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-12-000342
Filing Date
2012-07-18
Accepted
2012-07-18 19:55:34
Documents
1
Period of Report
2012-07-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2814
  Complete submission text file 0000904454-12-000342.txt   4235
Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address
Kamdar Kim P. (Reporting) CIK: 0001535065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35599 | Film No.: 12968837

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Issuer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations